This site is intended for healthcare professionals only
LoginRegister

Cardiology-CTVS Dialogues

Single Dose of zilebesiran Lowers Blood Pressure for Six Months: Phase 2 KARDIA study

Single Dose of zilebesiran Lowers Blood Pressure for Six Months: Phase 2 KARDIA study

A groundbreaking study presented at the American Heart Association's Scientific Sessions 2023 unveils promising results for a novel hypertension drug,...
View All

Latest News and Guidelines

Primary Prevention with Aspirin: Lowering ASCVD Mortality in Adults with Elevated Lipoprotein(a)

Primary Prevention with Aspirin: Lowering ASCVD Mortality in Adults with Elevated Lipoprotein(a)

Intravenous Tirofiban in Endovascular Stroke Thrombectomy

Tirofiban Boosts Reperfusion Success and Reduces Disability in Stroke Patients, RESCUE BT Trial...

surgery

Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery: ENBALV Trial Results

Invasive Versus Conservative Strategy in NSTEMI

Invasive Strategy Reduces Risks in Older Adults with Acute Coronary Syndrome, Research Finds

Study Provides Insights on NSAIDs Double Internal Bleeding Risk in Patients on Anticoagulants

Study Provides Insights on NSAIDs Double Internal Bleeding Risk in Patients on Anticoagulants

Asporin Promising Protective Target in Pulmonary Arterial Hypertension Identifies New Multiomics Study

Asporin Promising Protective Target in Pulmonary Arterial Hypertension Identifies New Multiomics...

View All
X